Adolor Corporation to Present at the Cowen and Company 29th Annual Health Care Conference
March 11 2009 - 7:30AM
Business Wire
Adolor Corporation (Nasdaq:ADLR) today announced that Michael R.
Dougherty, President and Chief Executive Officer, will present at
the Cowen and Company 29th Annual Health Care Conference on Monday,
March 16, 2009 at 3:55 P.M. Eastern Time. The conference is being
held at the Boston Marriott Copley Place, Boston,
Massachusetts.
Adolor�s presentation will be webcast live for investors through
www.adolor.com and available for a period of one week following the
conference.
About Adolor Corporation
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain management products.
Adolor�s first approved product in the United States is
ENTEREG�, which is indicated to accelerate the time to upper and
lower gastrointestinal recovery following partial large or small
bowel resection surgery with primary anastomosis. ENTEREG is
available for short-term use in hospitals registered under the
ENTEREG Access Support and Education (E.A.S.E.TM) Program. In
collaboration with GlaxoSmithKline, the Company launched ENTEREG in
mid-2008.
The Company�s research and development pipeline includes: two
novel delta opioid receptor agonists, currently in mid-stage
clinical development in collaboration with Pfizer Inc. for chronic
pain; a mu opioid receptor antagonist entering development for
chronic opioid bowel dysfunction (OBD); and several opioid and
non-opioid discovery programs.
For more information, visit www.adolor.com.
This press release is available on the website
http://www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Adolor Corp. (MM) (NASDAQ): 0 recent articles
More Adolor Corporation News Articles